Healthcare Industry News CSR News

Covid-19 Pandemic Puts Focus on Health Benefits Enrollment Season

by Tamara E. Holmes
Article

Every year, workers make changes to their benefits options during open enrollment season. But this time around, the COVID-19 pandemic had raised the importance of the annual process.

Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19

Summary: 

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

Article

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

By Liz Ozaist, Global Content Lab Editor-in-Chief, Johnson & Johnson
Summary: 

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

Blog

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

With COVID Causing Financial Strife, Americans Taking a Hard Look at Health Care Spending

Article

The hits just keep on coming for Americans struggling to keep up financially during a COVID-fueled economic downturn.

That’s the key takeaway from the annual 2020 Aflac WorkForces Report, which takes a magnifying glass to how employees and employers expect to approach health care benefits enrollment each year.

It’s not uncommon for Americans to adjust their health care benefits preferences, but the rising tide Aflac is seeing this year on other personal health care front is surprising.

The Science & Art of Goal Setting: Announcing Johnson & Johnson's New Climate Goals

by Paulette Frank, Worldwide Vice President, Environmental Health, Safety & Sustainability at Johnson & Johnson
Blog

I am so incredibly proud to have had the privilege to share Johnson & Johnson’s new climate goals during this Climate Week NYC 2020.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release

NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.

The Next Phase of Our COVID-19 Vaccine Development

by Alex Gorsky Chairman of the Board and Chief Executive Officer, Johnson & Johnson
Blog

It’s hard to believe that just six months have passed since our scientists identified Janssen’s lead COVID-19 vaccine candidate. We couldn’t have predicted all the changes that have happened since. Two things, however, have been constant: COVID-19 continues to be a devastating pandemic, and Johnson & Johnson has been working around the clock on a potential solution.

The Road to a Vaccine, Season 2, Ep. 7: Is It Really Safe for Schools to Be Open Right Now?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

The Ohio State University Wexner Medical Center Joins Healthcare Facility Advisory Board

Press Release

September 18, 2020 /3BL Media/ - The Healthcare Plastics Recycling Council (HPRC) is pleased to announce the appointment of The Ohio State University Wexner Medical Center to its Healthcare Facility Advisory Board (HFAB), a role intended to help the council set priorities and steer the agenda toward its mission of inspiring and enabling sustainable, cost-effective recycling solutions for plastic products and materials used in the delivery of healthcare.

Medtronic: Quality Care, From Anywhere

With a global pandemic still raging in parts of the world, Medtronic is helping stretched-thin clinicians work quickly, safely, and efficiently with the help of remote technology.
Article

When the COVID-19 crisis was hitting its apex in New York earlier this year, doctors needed a way to remotely monitor the vital signs of patients admitted to a large convention center that had been converted into a field hospital.

So, a team from Medtronic quickly installed several of the company’s technologies to create a system that allowed about 10 clinicians to remotely monitor about 400 patients at the Jacob K. Javits Convention Center.

Getting such an operation up and running normally takes weeks or months … Medtronic did it over a weekend.

Pages

Subscribe to Healthcare Industry News